Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05887817 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)

Name: Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) — clinical trial record (NCT05887817)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FIVE-STAR

StatusUnknown

PhasePhase 4

SponsorSaga University

Started2023-09-07

View on ClinicalTrials.gov ↗

Record status

This record was last updated February 7, 2024 (before its estimated February 28, 2025 completion). Its status may not reflect the trial's current state.

To evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease.

Amendment history 1 change detected by DataLookout

2026-08-09

Trial status changed: Active, Not Recruiting → Unknown

Trial Details

NCT Number	NCT05887817
Lead Sponsor	Saga University
Conditions	Type 2 Diabetes, Chronic Kidney Diseases
Enrollment	100 participants
Start Date	2023-09-07
Primary Completion	2025-02-28 (estimated)
Study Completion	2026-07-31 (estimated)
Updated on ClinicalTrials.gov	2024-02-07